您的位置: 首页 > 农业专利 > 详情页

The method for determining the therapeutic response probability in the cancer chemotherapy carried out with cardiac glycoside
专利权人:
PHOENIX BIOTECHNOLOGY INC.
发明人:
NEWMAN, ROBERT,NEWMAN ROBERT,YANG, PEIYING,YANG PEIYING,ADDINGTON, O.,ADDINGTON O
申请号:
ES08850574
公开号:
ES2414057T3
申请日:
2008.11.06
申请国别(地区):
ES
年份:
2013
代理人:
摘要:
The present invention provides prognosis measurement and kit and its application methods. A possibility that kit and measurement are for determining the diseased cells with etiologic etiological disease relevant to excessive cell proliferation or imbalance or organizing the therapeutic response treated for cardiac glycoside. The kit and measurement are for determining the Na for deriving from diseased cells or tissue, the isotype ratio of the α subunits of K-ATP enzymes. The kit can be used for predicting the therapeutic response that cancer or tumour treat cardiac glycoside in object. The kit and measurement can be mixed to be had in etiologic etiological disease relevant to excessive cell proliferation or the method for imbalance with the composition treatment containing cardiac glycoside.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充